ZTS.NYSEZoetis INC

Form 4: Zoetis CFO Joseph Wetteny Reports Stock Transactions

Sentiment:

Insider Transaction Report


Zoetis Inc.'s Chief Financial Officer, Joseph Wetteny, reported the acquisition of common stock through RSU vesting and subsequent disposition of shares for tax purposes.

Summary

  • Joseph Wetteny, Chief Financial Officer of Zoetis Inc. (ZTS), reported transactions involving the company's common stock.
  • On February 19, 2026, Wetteny acquired 2,050 shares of common stock through the vesting and settlement of restricted stock units (RSUs).
  • Following this acquisition, Wetteny's direct beneficial ownership of common stock was 22,816 shares.
  • On the same date, Wetteny disposed of 703 shares of common stock at a price of $127.28 per share.
  • After the disposition, Wetteny's direct beneficial ownership of common stock was 22,113 shares.
  • The disposition of shares was likely for tax withholding purposes related to the RSU vesting.
  • The filing also details remaining restricted stock units (RSUs) held by Wetteny, including 4,102, 8,605, and 1,389 units, which represent contingent rights to receive common stock upon future vesting.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral event, representing a routine insider transaction involving the vesting of restricted stock units and a subsequent sale to cover tax obligations, which is a common practice for executive compensation.

Positives

  • The vesting of 2,050 restricted stock units indicates continued service and compensation for the Chief Financial Officer, Joseph Wetteny.
  • The acquisition of common stock through RSU vesting increases the CFO's direct ownership in the company, aligning his interests with shareholders.

Negatives

  • The disposition of 703 shares of common stock, likely for tax withholding, reduces the CFO's direct beneficial ownership.

Future Outlook

The filing indicates future vesting events for outstanding Restricted Stock Units on the anniversaries of their grant dates (February 19, 2025; February 18, 2026; and February 6, 2024), subject to the reporting person's continued service.

Industry Context

StockSavvy.ai notes that routine insider transactions, such as RSU vesting and subsequent tax-related sales, are common across all industries, particularly in mature companies like Zoetis. These transactions typically reflect standard executive compensation practices rather than strategic shifts or market-moving insights.

Stakeholder Impact

  • Shareholders: The transaction is a routine compensation event and is unlikely to have a significant direct impact on shareholders. It reflects the ongoing alignment of executive incentives with company performance through equity awards.
  • Employees: No direct impact on employees is indicated by this filing.

Next Steps

  • Continued vesting of remaining Restricted Stock Units on their respective anniversary dates, subject to continued service.

Key Dates

DateDescription
02/06/2024Grant date for a tranche of Restricted Stock Units, with one-third vesting on its first, second, and third anniversaries.
02/19/2025Grant date for a tranche of Restricted Stock Units, with one-third vesting on its first, second, and third anniversaries.
02/18/2026Grant date for a tranche of Restricted Stock Units, with one-third vesting on its first, second, and third anniversaries.
02/19/2026Transaction date for the acquisition of common stock upon RSU vesting and the disposition of common stock.
02/23/2026Date the Form 4 was signed by the Attorney-in-Fact.

Keywords

Zoetis, ZTS, Form 4, Insider Transaction, Restricted Stock Units, RSU, Common Stock, CFO, Joseph Wetteny, Equity Compensation

Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.